We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.51B
AUM Growth
+$384M
Cap. Flow
-$139M
Cap. Flow %
-1.86%
Top 10 Hldgs %
12.57%
Holding
653
New
84
Increased
171
Reduced
267
Closed
86

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$31.4M
2
LSCC icon
Lattice Semiconductor
LSCC
+$30.1M
3
ONTO icon
Onto Innovation
ONTO
+$27.5M
4
FELE icon
Franklin Electric
FELE
+$24.1M
5
ROCK icon
Gibraltar Industries
ROCK
+$22.7M

Top Sells

Rank Stock Value
1
MP icon
MP Materials
MP
+$47.1M
2
REVG
REV Group
REVG
+$42.9M
3
FICO icon
Fair Isaac
FICO
+$25.6M
4
PWR icon
Quanta Services
PWR
+$22.1M
5
MRVL icon
Marvell Technology
MRVL
+$20.3M

Sector Composition

Rank Sector Weight
1 Technology 22.39%
2 Industrials 18.02%
3 Financials 14.65%
4 Consumer Discretionary 11.88%
5 Healthcare 11.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARES icon
251
Ares Management
ARES
$32.2B
$8.85M 0.12%
55,345
-109,594
-66% -$19.8M
IJH icon
252
iShares Core S&P Mid-Cap ETF
IJH
$126B
$8.83M 0.12%
135,277
+46,187
+52% +$2.97M
ABBV icon
253
AbbVie
ABBV
$431B
$8.77M 0.12%
37,860
-2
-0% -$407
RSG icon
254
Republic Services
RSG
$63.9B
$8.71M 0.12%
37,970
-12,164
-24% -$2.85M
MGRC icon
255
McGrath RentCorp
MGRC
$2.94B
$8.63M 0.12%
73,596
+1,808
+3% +$218K
BCRX icon
256
BioCryst Pharmaceuticals
BCRX
$2.29B
$8.61M 0.11%
1,134,813
-85,264
-7% -$710K
PTGX icon
257
Protagonist Therapeutics
PTGX
$8.73B
$8.18M 0.11%
123,125
+2,966
+2% +$169K
TKR icon
258
Timken Company
TKR
$9.18B
$8.11M 0.11%
+107,835
New +$8.32M
ADI icon
259
Analog Devices
ADI
$185B
$8M 0.11%
32,556
+4,898
+18% +$1.18M
CDE icon
260
Coeur Mining
CDE
$16.7B
$7.99M 0.11%
425,953
-22,292
-5% -$273K
CHD icon
261
Church & Dwight Co
CHD
$24.4B
$7.98M 0.11%
91,108
-5,209
-5% -$488K
USLM icon
262
United States Lime & Minerals
USLM
$3.32B
$7.94M 0.11%
+60,330
New +$6.96M
SMG icon
263
ScottsMiracle-Gro
SMG
$3.86B
$7.85M 0.1%
137,805
-3,748
-3% -$236K
JPEM icon
264
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$393M
$7.77M 0.1%
131,773
-7,787
-6% -$450K
IHG icon
265
InterContinental Hotels
IHG
$23.3B
$7.75M 0.1%
63,909
-3,867
-6% -$463K
NDAQ icon
266
Nasdaq
NDAQ
$52.3B
$7.67M 0.1%
86,671
-4,683
-5% -$434K
NBIX icon
267
Neurocrine Biosciences
NBIX
$16.9B
$7.65M 0.1%
54,474
+9,383
+21% +$1.27M
KNSL icon
268
Kinsale Capital Group
KNSL
$8.26B
$7.64M 0.1%
17,955
+445
+3% +$202K
CRNX icon
269
Crinetics Pharmaceuticals
CRNX
$8.9B
$7.53M 0.1%
180,849
+4,332
+2% +$139K
AVY icon
270
Avery Dennison
AVY
$13.3B
$7.52M 0.1%
46,351
-2,854
-6% -$492K
LMAT icon
271
LeMaitre Vascular
LMAT
$2.42B
$7.45M 0.1%
85,159
+2,364
+3% +$211K
DNLI icon
272
Denali Therapeutics
DNLI
$3.84B
$7.45M 0.1%
512,958
+12,399
+2% +$178K
PRCT icon
273
Procept Biorobotics
PRCT
$1.04B
$7.44M 0.1%
208,539
+5,098
+3% +$233K
GERN icon
274
Geron
GERN
$860M
$7.31M 0.1%
5,335,216
-1,856,968
-26% -$2.47M
GNTX icon
275
Gentex
GNTX
$5.14B
$7.3M 0.1%
257,822
-333,569
-56% -$8.86M
9 10
11
12 13

Similar funds

DE
Defiance ETFs New York $6.98B AUM
STA
Summit Trail Advisors New York $6.98B AUM 19.51% 1-Year Est. Return
OCA
OpenArc Corporate Advisory Atlanta, Georgia $6.98B AUM
PFA
Pure Financial Advisors San Diego, California $6.97B AUM 16.14% 1-Year Est. Return
CWM
Circle Wealth Management Summit, New Jersey $7.02B AUM 19.32% 1-Year Est. Return
RPI
Railway Pension Investments London, United Kingdom $7.03B AUM 18.92% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Segall Bryant & Hamill's Q3 2025 Portfolio in Review

As of Q3 2025, Segall Bryant & Hamill held 653 positions worth $7.51B, up 5.4% from $7.12B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Segall Bryant & Hamill's Q3 2025 filing shows 84 new, 171 increased, 267 reduced and 86 closed positions. Its largest new stake was Lattice Semiconductor: 493,924 shares worth $36.2M. The largest sale was MP Materials, an estimated $47.1M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q3 2025 buy was Lattice Semiconductor: 493,924 shares worth $36.2M.
  • Segall Bryant & Hamill added most to NVIDIA in Q3 2025, an estimated $31.4M increase.
  • Segall Bryant & Hamill's biggest Q3 2025 reduction was MP Materials, cutting an estimated $47.1M.
  • Segall Bryant & Hamill fully exited Fair Isaac in Q3 2025, selling an estimated $25.6M.
  • Segall Bryant & Hamill's ten largest holdings make up 13% of its $7.51B portfolio in Q3 2025.
  • Segall Bryant & Hamill opened 84 new positions and closed 86 in Q3 2025.
  • Segall Bryant & Hamill's portfolio value rose 5.4% quarter-over-quarter to $7.51B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2025, filed 12 Nov 2025.